{"url_path":"/sec/icucw/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1831868/0001437749-26-016764-index.html","accession_number":"0001437749-26-016764","cik":"0001831868","ticker":"ICU","issuer_name":"SeaStar Medical Holding Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1831868/0001437749-26-016764-index.html","primary_entity_key":"0001831868","primary_entity_name":"SeaStar Medical Holding Corp"},"word_count":47,"has_tables":true,"body_markdown":"**Item 5. Other Information.**\n\n \n\nDuring the *three* months ended *March 31, 2026*, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-*1* trading arrangement,” as each term is defined in Item *408*(a) of Regulation S-K.    \n\n \n\n \n\n32\n\n[Table of Contents](#toc)"}